News
CLB
17.08
+0.53%
0.09
U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map
Home Stock Ideas Quick Picks & Lists U.S. Wide-Moat Stocks On Sale - The March 2024 Heat Map. Our 3-step process focuses on wide-moat stocks with 5-star and 4-star ratings. Morningstar's moat rating is a good indicator of market sentiment. We share the heat map of the most investable candidates for further analysis.
Seeking Alpha · 1d ago
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?
Core Laboratories Inc. (NYSE:CLB) is estimated to be 25% undervalued. Its fair value is 19% higher than current share price of US$17.15. We will use a discounted cash flow model to estimate the intrinsic value of the company. The projected fair value for Core Laboratories is US$22.93 based on 2 Stage Free Cash Flow to Equity.
Simply Wall St · 2d ago
Core Laboratories Appoints New VP and Chief Accounting Officer
TipRanks · 3d ago
CORE LABORATORIES' FIRST QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 25, 2024
Core Laboratories will broadcast its first quarter 2024 conference call over the Internet at 7:30 a.m. CDT on April 25, 2024. Larry Bruno, Chairman and CEO, will discuss financial and operational results. Core Laboratories is a leading provider of reservoir description and production enhancement services.
PR Newswire · 3d ago
Weekly Report: what happened at CLB last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at CLB last week (0311-0315)?
Weekly Report · 03/18 09:06
A year after the regional banking crisis, is there more trouble on the horizon?
Seeking Alpha · 03/11 11:15
Weekly Report: what happened at CLB last week (0304-0308)?
Weekly Report · 03/11 09:06
Weekly Report: what happened at CLB last week (0226-0301)?
Weekly Report · 03/04 09:06
Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price
Core Laboratories Inc.'s price-to-earnings ratio of 19.8x is higher than the market in the United States. The company grew earnings per share by 87% last year and is expected to grow earnings by 32% in the coming years. The high P/E may be due to the company's forecast growth over the long-term. Core Laboratories has a high price to earnings ratio compared to other companies in its industry.
Simply Wall St · 03/02 12:20
Weekly Report: what happened at CLB last week (0219-0223)?
Weekly Report · 02/26 09:07
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
Canadian medical cannabis giant Aurora Cannabis Inc. Has appointed Simona King as its new CEO. The company also announced the consolidation of its common shares on a 10 to 1 basis. Cresco Labs Inc. And The Hempshire Group, Inc. Have also named new CEOs and CFOs.
Benzinga · 02/20 14:11
Core Laboratories (CLB) Gets a Hold from Piper Sandler
TipRanks · 02/20 12:45
Weekly Report: what happened at CLB last week (0212-0216)?
Weekly Report · 02/19 09:07
Core Laboratories (CLB) Shares Enter Oversold Territory
NASDAQ · 02/13 20:51
U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map
Home Stock Ideas Quick Picks & Lists U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map. Morningstar's 3-step process focuses on wide-moat stocks with 5-star and 4-star ratings. As of February 12, there were 152 U.s. Wide- moat stocks meeting our criteria. Only 2.6% of these companies earned a 5- star valuation rating.
Seeking Alpha · 02/13 05:39
Weekly Report: what happened at CLB last week (0205-0209)?
Weekly Report · 02/12 09:07
New York Community Bancorp plunges again after Moody's downgrades to junk
Seeking Alpha · 02/07 11:04
Core Labs Price Target Cut to $17.00/Share From $21.00 by Stifel
Dow Jones · 02/05 21:16
Core Labs Is Maintained at Hold by Stifel
Dow Jones · 02/05 21:16
More
Webull provides a variety of real-time CLB stock news. You can receive the latest news about Core Laboratories Inc through multiple platforms. This information may help you make smarter investment decisions.
About CLB
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.